Amyloidosis caused by systemic deposition of transthyretin (TTR) is called ATTR
amyloidosis and mainly includes hereditary ATTR (ATTRv) amyloidosis and wild-type ATTR …

Introduction The coronavirus disease 2019 (COVID‐19) pandemic has hampered the
progress of neurological healthcare services for patients across Africa. Before the pandemic …

It is well known that the spectrum of SARS-CoV-2 infection ranges from asymptomatic or
mildly symptomatic patients to rapidly progressive, acute respiratory distress syndrome …

Background: Findings from autopsies have provided evidence on systemic microvascular
damage as one of the underlying mechanisms of Coronavirus disease 2019 (CO-VID-19) …

Abstract In 2019-2020, the SARS-CoV-2 pandemic has shocked the world and most health
care systems, and a “second wave” of the viral spread is ongoing in Europe and in Italy too …

There are regular reports of extrapulmonary infections and manifestations related to the
ongoing COVID-19 pandemic. Coronaviruses are potentially neurotropic, which renders …

Background The COVID-19 pandemic presents two main concerns for patients with
myasthenia gravis (MG); chronic immunosuppression may put them at greater risk, and …

Background and purpose The objective of this study was to assess the neurological
manifestations in a series of consecutive severe acute respiratory syndrome coronavirus 2 …

COVID-19, a respiratory viral infection, has affected more than 10 million individuals
worldwide. Common symptoms include fever, dry cough, fatigue and shortness of breath …

Background: It is essential to study the effect of potential co-factors on the risk of death in
patients infected by COVID-19. The identification of risk factors is important to allow more …